George Budwell has been writing about healthcare and biotechnology companies at the Motley Fool since 2013. His primary interests are novel small molecule drugs, next generation vaccines, and cell therapies.
Recent Articles by George Budwell
HOW THE MOTLEY FOOL CAN HELP YOU
Premium Investing Guidance
Market beating stocks from our award-winning service
The Daily Upside Newsletter
Investment news and high-quality insights delivered straight to your inbox
Get Started Investing
You can do it. Successful investing in just a few steps
Win at Retirement
Secrets and strategies for the post-work life you want.
Find a Broker
Find the right brokerage account for you.
Listen to our Podcasts
Hear our experts take on stocks, the market, and how to invest.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.